Simplex Trading
CRDL

Simplex Trading’s Cardiol Therapeutics CRDL Stock Holding History

Simplex Trading’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,900
Closed -$3K – 8658
2024
Q3 		$3K Hold
1,900
– – ﹤0.01% 7818
2024
Q2 		$3K Buy
+1,900
New +$4.03K ﹤0.01% 8092
2024
Q1 		– Sell
-2,000
Closed -$1K – 8978
2023
Q4 		$1K Buy
2,000
+500
+33% +$425 ﹤0.01% 8453
2023
Q3 		$1K Sell
1,500
-1,600
-52% -$1.53K ﹤0.01% 8272
2023
Q2 		$2K Buy
+3,100
New +$2.05K ﹤0.01% 8383
2022
Q2 		– Sell
-28,900
Closed -$44K – 10098
2022
Q1 		$44K Sell
28,900
-3,200
-10% -$5.28K ﹤0.01% 7307
2021
Q4 		$59K Buy
+32,100
New +$88.7K ﹤0.01% 7032

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's CRDL Position: Q1 2026 in Review

Simplex Trading sold out of Cardiol Therapeutics (CRDL) in Q1 2026, closing a stake of 32,197 shares — an estimated $33K sold.

Simplex Trading first reported a position in CRDL in Q1 2022 and held it in 6 quarters. The position peaked at $37K in Q1 2022. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Simplex Trading reported no remaining Cardiol Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 32,197 Cardiol Therapeutics shares in Q1 2026, an estimated $33K.
  • Simplex Trading first reported a position in Cardiol Therapeutics in Q1 2022 and held it in 6 quarters.
  • Simplex Trading's Cardiol Therapeutics position peaked at $37K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.